WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that it plans to report its financial results for its fiscal fourth quarter and year ended September 30, 2015 after the U.S. markets close on November 23, 2015. Enanta management will host a conference call at 4:30 p.m. ET to discuss these results and provide an update on Enanta’s research and development pipeline.
Help employers find you! Check out all the jobs and post your resume.
